 Agios Pharmaceuticals, Inc. NASDAQ:AGIO Q3 2022 Earnings Conference Call November 3, 2022 8:00 AM ET Company Participants Holly Manning - Investor Relations Brian Goff - Chief Executive Officer Sarah Gheuens - Chief Medical Officer and Head, Research and Development Richa Poddar - Chief Commercial Officer Cecilia Jones - Chief Financial Officer Conference Call Participants Marc Frahm - Cowen Mark Breidenbach - Oppenheimer Andy Berens - SVB Andrea Tan - Goldman Sachs Danielle Brill - Raymond James Operator Good day and thank you for standing by and welcome to Q3 2022 Agios Pharmaceuticals, Inc. Earnings Conference Call. Operator Instructions Please be advised that todays conference is being recorded. 